Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2017-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the errors that may occur during inhalation of two devices in patients with asthma, as well as to study whether it relates to the degree of control of patient symptoms and the degree of compliance of medication symptoms. Finally, we also want to study the degree of patient satisfaction with each of the inhalers studied

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.

NCT06732882

Asthma

COMPLETED PHASE1

To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma

NCT02195284

Asthma

COMPLETED PHASE4

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314

Asthma

COMPLETED

Bronchial Thermoplasty in Severe Asthma With Frequent Exacerbations

NCT02464995

Asthma

UNKNOWN NA

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

NCT01424813

Asthma

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with asthma with an inhaled steroid

Patients with a diagnosis of asthma with indication of Treatment with an inhaled steroid (CI)

TURBUHALER®

Intervention Type DEVICE

Patients with asthma with an inhaled Beta agonist

Patients with a diagnosis of asthma with indication of Treatment with an inhaled Beta agonist (LABA)

SPIROMAX®

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TURBUHALER®

Intervention Type DEVICE

SPIROMAX®

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of asthma with treatment indication with CI + LABA according to GINA 2015 guide and in dry powder device.
* Over 18 years.
* Patient in stable phase without having had exacerbations in the 3 months previous to the Inclusion in the study

Exclusion Criteria

* Presence of relevant respiratory disease other than asthma (including COPD).
* Refusal to participate in the study and sign informed consent or inability to To give informed consent.
* Patients who have previously been treated with inhaled dust devices dry.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No